Published in J Immunol on November 15, 1996
Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice. Infect Immun (1998) 2.12
Persistence of Borrelia burgdorferi following antibiotic treatment in mice. Antimicrob Agents Chemother (2008) 2.02
Dual role of interleukin-10 in murine Lyme disease: regulation of arthritis severity and host defense. Infect Immun (1999) 1.91
Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14. Infect Immun (1999) 1.50
Association of linear plasmid 28-1 with an arthritic phenotype of Borrelia burgdorferi. Infect Immun (2005) 1.30
Toll-like receptors: molecular mechanisms of the mammalian immune response. Immunology (2000) 1.27
Recruitment of macrophages and polymorphonuclear leukocytes in Lyme carditis. Infect Immun (2006) 1.12
Viable Borrelia burgdorferi enhances interleukin-10 production and suppresses activation of murine macrophages. Infect Immun (2007) 1.01
Role of Fc gamma receptors in triggering host cell activation and cytokine release by Borrelia burgdorferi. Infect Immun (2001) 1.00
Murine Lyme arthritis development mediated by p38 mitogen-activated protein kinase activity. J Immunol (2002) 0.97
Novel microbial virulence factor triggers murine lyme arthritis. J Infect Dis (2013) 0.92
Listeria monocytogenes virulence factors that stimulate endothelial cells. Infect Immun (1998) 0.91
Borrelia burgdorferi and interleukin-1 promote the transendothelial migration of monocytes in vitro by different mechanisms. Infect Immun (1998) 0.88
Borrelia burgdorferi induces chemokines in human monocytes. Infect Immun (1997) 0.87
Borrelia burgdorferi spirochetes induce mast cell activation and cytokine release. Infect Immun (1999) 0.87
Infectivity of the highly transformable BBE02- lp56- mutant of Borrelia burgdorferi, the Lyme disease spirochete, via ticks. Infect Immun (2006) 0.86
Tripalmitoyl-S-glyceryl-cysteine-dependent OspA vaccination of toll-like receptor 2-deficient mice results in effective protection from Borrelia burgdorferi challenge. Infect Immun (2003) 0.84
Infection of human endothelial cells with Bartonella bacilliformis is dependent on Rho and results in activation of Rho. Infect Immun (2000) 0.84
Forward genetic approaches for elucidation of novel regulators of Lyme arthritis severity. Front Cell Infect Microbiol (2014) 0.84
Borrelia burgdorferi lipoprotein BmpA activates pro-inflammatory responses in human synovial cells through a protein moiety. Microbes Infect (2008) 0.83
Direct evidence for involvement of NF-kappaB in transcriptional activation of tumor necrosis factor by a spirochetal lipoprotein. Infect Immun (2000) 0.81
OspA heterogeneity of Borrelia valaisiana confirmed by phenotypic and genotypic analyses. BMC Infect Dis (2003) 0.81
Genetic loci of major antigenic protein genes of Edwardsiella tarda. Appl Environ Microbiol (2005) 0.80
CD14 signaling reciprocally controls collagen deposition and turnover to regulate the development of lyme arthritis. Am J Pathol (2011) 0.79
Presence of Arp specifically contributes to joint tissue edema associated with early-onset Lyme arthritis. Infect Immun (2013) 0.78
E and P selectins are not required for resistance to severe murine lyme arthritis. Infect Immun (1998) 0.77
The Cross-Talk between Spirochetal Lipoproteins and Immunity. Front Immunol (2014) 0.76
Toll-like receptor cascade and gene polymorphism in host-pathogen interaction in Lyme disease. J Inflamm Res (2016) 0.76
The Potential of Omics Technologies in Lyme Disease Biomarker Discovery and Early Detection. Infect Dis Ther (2016) 0.75
Spirochetal Lipoproteins and Immune Evasion. Front Immunol (2017) 0.75
Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques (1998) 11.39
Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol (2000) 6.68
Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci U S A (1984) 6.62
Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature (1990) 5.17
Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J Immunol (1999) 3.80
Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun (2001) 3.55
Platelet-activating factor and related lipid mediators. Annu Rev Biochem (2000) 3.44
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest (1995) 3.14
Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today (1992) 3.06
Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J Cell Biol (1991) 3.05
Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Invest (2001) 3.01
Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues. Infect Immun (1994) 2.81
Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature (1995) 2.79
Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol (2001) 2.75
Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proc Natl Acad Sci U S A (1984) 2.71
Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem (1993) 2.61
Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol (1991) 2.59
Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J Clin Invest (1985) 2.58
Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest (1996) 2.51
Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J Exp Med (1992) 2.47
Rapid and sensitive quantification of Borrelia burgdorferi-infected mouse tissues by continuous fluorescent monitoring of PCR. J Clin Microbiol (1999) 2.39
Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Proc Natl Acad Sci U S A (1984) 2.28
Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase. J Clin Invest (1996) 2.21
Protein kinase C regulates the nuclear localization of diacylglycerol kinase-zeta. Nature (1998) 2.20
Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. Proc Natl Acad Sci U S A (1986) 2.18
Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect Immun (1993) 2.18
Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. J Clin Invest (1985) 2.16
Intracellular localization of Borrelia burgdorferi within human endothelial cells. Infect Immun (1991) 2.13
Platelet-activating factor. J Biol Chem (1990) 2.13
Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice. Infect Immun (1998) 2.12
Neutrophil adherence to human endothelium in vitro occurs by CDw18 (Mo1, MAC-1/LFA-1/GP 150,95) glycoprotein-dependent and -independent mechanisms. J Clin Invest (1988) 2.12
Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation. J Clin Invest (1995) 2.06
Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3'-untranslated region. J Biol Chem (2000) 2.05
Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci U S A (1998) 1.97
A complement receptor locus: genes encoding C3b/C4b receptor and C3d/Epstein-Barr virus receptor map to 1q32. J Immunol (1987) 1.94
Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor. J Biol Chem (1987) 1.93
Dual role of interleukin-10 in murine Lyme disease: regulation of arthritis severity and host defense. Infect Immun (1999) 1.91
Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc Natl Acad Sci U S A (1996) 1.88
Inflammatory roles of P-selectin. J Clin Invest (1993) 1.87
Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking. J Clin Invest (1997) 1.87
Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists. J Biol Chem (2001) 1.86
Intracellular unesterified arachidonic acid signals apoptosis. Proc Natl Acad Sci U S A (2000) 1.85
Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion. J Cell Biol (1990) 1.84
Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates. J Biol Chem (1991) 1.71
Evidence for B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice. Infect Immun (1992) 1.71
Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J Clin Invest (1995) 1.66
Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway. Infect Immun (1994) 1.66
The leukocyte integrins. J Biol Chem (2000) 1.65
Human plasma platelet-activating factor acetylhydrolase. Purification and properties. J Biol Chem (1987) 1.55
Platelet-activating factor acetylhydrolases. J Biol Chem (1997) 1.51
Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. J Clin Invest (1988) 1.51
Activation of human neutrophil phospholipase D by three separable mechanisms. FASEB J (1990) 1.50
An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma. J Biol Chem (1989) 1.48
Immunity to Lyme disease: protection, pathology and persistence. Curr Opin Immunol (1996) 1.48
Endothelial cell inflammatory responses to tumor necrosis factor alpha. Ceramide-dependent and -independent mitogen-activated protein kinase cascades. J Biol Chem (1996) 1.47
Resistance to Lyme disease in decorin-deficient mice. J Clin Invest (2001) 1.46
Neutrophil activating factor (NAF) induces polymorphonuclear leukocyte adherence to endothelial cells and to subendothelial matrix proteins. Biochem Biophys Res Commun (1989) 1.46
Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein. J Biol Chem (1999) 1.46
Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J Clin Invest (1995) 1.44
Plasma platelet-activating factor acetylhydrolase is a secreted phospholipase A2 with a catalytic triad. J Biol Chem (1995) 1.44
Platelet-activating factor acetylhydrolase increases during macrophage differentiation. A novel mechanism that regulates accumulation of platelet-activating factor. J Biol Chem (1989) 1.42
Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement. Proc Natl Acad Sci U S A (1986) 1.42
Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA. Infect Immun (1994) 1.40
Molecular cloning of a novel human diacylglycerol kinase highly selective for arachidonate-containing substrates. J Biol Chem (1996) 1.39
Saliva of the tick Ixodes dammini inhibits neutrophil function. Exp Parasitol (1990) 1.38
The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. J Immunol (1998) 1.38
Resistance to phagocytosis by group A streptococci: failure of deposited complement opsonins to interact with cellular receptors. J Immunol (1985) 1.37
Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells. J Biol Chem (1999) 1.35
Expression of the mouse fragilis gene products in immune cells and association with receptor signaling complexes. Genes Immun (2006) 1.35
Demonstration of a B-lymphocyte mitogen produced by the Lyme disease pathogen, Borrelia burgdorferi. Infect Immun (1992) 1.33
Borrelia burgdorferi outer surface protein A (OspA) activates and primes human neutrophils. J Immunol (1997) 1.31
Somatic cell cloning in polyester stacks. Proc Natl Acad Sci U S A (1982) 1.31
Host-pathogen interactions promoting inflammatory Lyme arthritis: use of mouse models for dissection of disease processes. Curr Opin Microbiol (2001) 1.31
Molecular cloning and characterization of a novel human diacylglycerol kinase zeta. J Biol Chem (1996) 1.31
CD11b/CD18 integrin and a beta-glucan receptor act in concert to induce the synthesis of platelet-activating factor by monocytes. J Immunol (1994) 1.30
The identification of N-linked oligosaccharides on the human CR2/Epstein-Barr virus receptor and their function in receptor metabolism, plasma membrane expression, and ligand binding. J Biol Chem (1985) 1.29
Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor. J Biol Chem (1991) 1.29
Thrombin stimulates neutrophil adherence by an endothelial cell-dependent mechanism: characterization of the response and relationship to platelet-activating factor synthesis. Ann N Y Acad Sci (1986) 1.28
Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. J Clin Invest (1997) 1.28
Adhesion and signaling in vascular cell--cell interactions. J Clin Invest (1996) 1.27
Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism. J Immunol (1987) 1.25
Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines. J Biol Chem (1999) 1.25
Platelet-activating factor: a phospholipid autacoid with diverse actions. J Lipid Res (1993) 1.25
Activation of polymorphonuclear leukocytes reduces their adhesion to P-selectin and causes redistribution of ligands for P-selectin on their surfaces. J Clin Invest (1995) 1.22
Integrin-dependent control of translation: engagement of integrin alphaIIbbeta3 regulates synthesis of proteins in activated human platelets. J Cell Biol (1999) 1.21
Mutants of Escherichia coli defective in membrane phospholipid synthesis. Effects of cessation and reinitiation of phospholipid synthesis on macromolecular synthesis and phospholipid turnover. J Biol Chem (1977) 1.20
Human macrophages secret platelet-activating factor acetylhydrolase. J Biol Chem (1990) 1.20
Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation. J Biol Chem (1998) 1.19
Platelet-activating factor acetylhydrolase from human plasma. Methods Enzymol (1990) 1.17
Genetic control of susceptibility to experimental Lyme arthritis is polygenic and exhibits consistent linkage to multiple loci on chromosome 5 in four independent mouse crosses. Genes Immun (2001) 1.17
The regulation of platelet-activating factor production in endothelial cells. The role of calcium and protein kinase C. J Biol Chem (1989) 1.16
Alpha toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells. J Clin Invest (1997) 1.16
Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules. J Clin Invest (1997) 1.12
The platelet-activating factor acetylhydrolase from human plasma prevents oxidative modification of low-density lipoprotein. Trans Assoc Am Physicians (1992) 1.12
Cloning, expression, and chromosomal localization of human long-chain fatty acid-CoA ligase 4 (FACL4). Genomics (1998) 1.12
Bioactive phospholipid oxidation products. Free Radic Biol Med (2000) 1.11
Platelet-activating factor: a mediator for clinicians. J Intern Med (1995) 1.11
Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology. Infect Immun (1995) 1.11
Mammalian platelet-activating factor acetylhydrolases. Biochim Biophys Acta (1996) 1.09
Novel leukocyte agonists are released by endothelial cells exposed to peroxide. J Biol Chem (1992) 1.09